122
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Hybrid polymeric microspheres for enhancing the encapsulation of phenylethyl resorcinol

, , &
Pages 130-139 | Received 31 Dec 2018, Accepted 10 Apr 2019, Published online: 14 May 2019

References

  • Chaisri, W., Hennink, W.E., and Okonogi, S., 2009. Preparation and characterization of cephalexin loaded PLGA microspheres. Current drug delivery, 6 (1), 69–75.
  • Chang, T.S., 2009. An updated review of tyrosinase inhibitors. International journal of molecular sciences, 10 (6), 2440–2475.
  • Doktorovova, S., Souto, E.B., and Silva, A.M., 2014. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – a systematic review of in vitro data. European journal of pharmaceutics and biopharmaceutics: official journal of arbeitsgemeinschaft fur pharmazeutische verfahrenstechnik e.v, 87 (1), 1–18.
  • Gold, M.H., and Biron, J., 2011. Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma. Journal of cosmetic dermatology, 10 (3), 189–196.
  • Gómez-Gaete, C., et al., 2007. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. International journal of pharmaceutics, 331 (2), 153–159.
  • Huang, W., et al., 2014. Microsphere based scaffolds for bone regenerative applications. Biomaterials science, 2 (9), 1145–1153.
  • Hunt, G., et al., 1994. Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. Journal of cell science, 107 (1), 205–211.
  • Jemec, G.B., and Serup, J., 1990. Epidermal hydration and skin mechanics. The relationship between electrical capacitance and the mechanical properties of human skin in vivo. Acta dermato-venereologica, 70 (3), 245–247.
  • Kamaly, N., et al., 2016. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chemical reviews, 116 (4), 2602–2663.
  • Kim, B.S., et al., 2017. The improvement of skin whitening of phenylethyl resorcinol by nanostructured lipid carriers. Nanomaterials (basel), 7 (9), 241.
  • Kim, K.N., et al., 2013. Octaphlorethol A isolated from Ishige foliacea inhibits alpha-MSH-stimulated induced melanogenesis via ERK pathway in B16F10 melanoma cells. Food and chemical toxicology: an international journal published for the British industrial biological research association, 59, 521–526.
  • Lane, M.E., 2013. Skin penetration enhancers. International journal of pharmaceutics, 447 (1-2), 12–21.
  • Limsuwan, T., et al., 2017. Ethosomes of phenylethyl resorcinol as vesicular delivery system for skin lightening applications. Biomed research international, 2017 (115), 1–12.
  • Makadia, H.K., and Siegel, S.J., 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers ( polymers), 3 (3), 1377–1397.
  • Narvekar, M., et al., 2014. A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer. Europian Journal of pharmaceutics and biopharmaceutics, 88 (1), 226–237.
  • Narvekar, M., Xue, H.Y., and Wong, H.L., 2012. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA). International journal of pharmaceutics, 436 (1-2), 721–731.
  • Ng, S.M., et al., 2010. Novel microencapsulation of potential drugs with low molecular weight and high hydrophilicity: hydrogen peroxide as a candidate compound. Clinical and experimental pharmacology, 384 (1-2), 120–127.
  • Odeku, O.A., et al., 2017. Formulation of floating metronidazole microspheres using cassava starch (Manihot esculenta) as polymer. Journal of pharmaceutical investigation, 47 (5), 445–451.
  • Prow, T.W., et al., 2011. Nanoparticles and microparticles for skin drug delivery. Advanced drug delivery reviews, 63 (6), 470–491.
  • Ramazani, F., et al., 2015. Formulation and characterization of microspheres loaded with imatinib for sustained delivery. International journal of pharmaceutics, 482 (1-2), 123–130.
  • Ramazani, F., et al., 2016. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges. International journal of pharmaceutics, 499 (1-2), 358–367.
  • Rolland, A., et al., 1993. Site-specific drug-delivery to pilosebaceous structures using polymeric microspheres. Pharmaceutical research, 10 (12), 1738–1744.
  • Sabzevari, A., et al., 2013. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies. European journal of pharmaceutics and biopharmaceutics, 84 (1), 63–71.
  • Sahoo, S.K., et al., 2002. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of controlled release : official journal of the controlled release society, 82 (1), 105–114.
  • Schmaus, G., et al., 2006. 4-(1-Phenylethyl) 1,3-benzenediol: a new highly potent lightening agent. Journal of cosmetic science, 57 (2), 197–198.
  • Sellers, D.L., et al., 2014. Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong hirudin delivery and improve functional recovery from a demyelination lesion. Biomaterials, 35 (31), 8895–8902.
  • Solano, F., et al., 2006. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment cell research, 19 (6), 550–571.
  • Song, X., et al., 2008. Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. European journal of pharmaceutics and biopharmaceutics, 69 (2), 445–453.
  • Soppimath, K.S., et al., 2001. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of controlled release : official journal of the controlled release society, 70 (1-2), 1–20.
  • Tabata, Y., and Ikada, Y., 1990. Phagocytosis of polymer microspheres by macrophages. In: New polymer materials. New York, NY: Springer Science & Business Media; 107–141.
  • Tallarida, R., and Jacob, L. S., 2012. The dose—response relation in pharmacology. New York, NY: Springer Science & Business Media;
  • Thote, A.J., et al., 2005. Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs. Drug development and industrial pharmacy, 31 (1), 43–57.
  • Vert, M., et al., 1998. Something new in the field of PLA/GA bioresorbable polymers? Journal of controlled release : official journal of the controlled release society, 53 (1-3), 85–92.
  • Wang, Q., et al., 2014. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation. Biomaterials, 35 (29), 8385–8393.
  • Wilems, T.S., and Sakiyama-Elbert, S.E., 2015. Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury. Journal of controlled release : official journal of the controlled release society, 213, 103–111.
  • Yao, S., et al., 2016. Drug-nanoencapsulated PLGA microspheres prepared by emulsion electrospray with controlled release behavior. Regenerative biomaterials, 3 (5), 309–317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.